{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T17:23:15Z","timestamp":1783963395382,"version":"3.55.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1097\/shk.0b013e318142c5df","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T14:10:23Z","timestamp":1236262223000},"page":"417-421","source":"Crossref","is-referenced-by-count":11,"title":["REDUCED VASCULAR RESPONSE TO PHENYLEPHRINE DURING EXPOSURE TO LIPOPOLYSACCHARIDE IN VITRO INVOLVES NITRIC OXIDE AND ENDOTHELIN 1"],"prefix":"10.1097","volume":"29","author":[{"given":"Johann K.","family":"Scicluna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Mansart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zo\u00eb L.S.","family":"Brookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"R1-17-20210213","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jama.1995.03520260039030","article-title":"The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.","volume":"273","author":"Rangel-Frausto","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"R2-17-20210213","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00024382-199603000-00002","article-title":"Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines.","volume":"5","author":"Battistini","year":"1996","journal-title":"Shock"},{"key":"R3-17-20210213","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1009720323448","article-title":"The discovery of nitric oxide as a key mediator in septic shock.","volume":"1","author":"Kilbourne","year":"1998","journal-title":"Sepsis"},{"issue":"3","key":"R4-17-20210213","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00000658-199103000-00014","article-title":"Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis.","volume":"213","author":"Pittet","year":"1991","journal-title":"Ann Surg"},{"issue":"2","key":"R5-17-20210213","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0306-3623(96)00410-7","article-title":"Nitric oxide and septic shock.","volume":"29","author":"Theimermann","year":"1997","journal-title":"Gen Pharmacol"},{"key":"R6-17-20210213","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0006-291X(89)91372-7","article-title":"Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay.","volume":"161","author":"Sugiura","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"R7-17-20210213","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0014-2999(92)90311-Q","article-title":"Endothelium-accelerated hyporesponsiveness of norepinephrine-elicited contraction of rat aorta in the presence of bacterial lipopolysaccharide.","volume":"219","author":"Nakaki","year":"1992","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"R8-17-20210213","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1476-5381.1992.tb09021.x","article-title":"Induction and potential biological relevance of a Ca2+-independent nitric oxide synthase in the myocardium.","volume":"105","author":"Schulz","year":"1992","journal-title":"Br J Pharmacol"},{"issue":"8","key":"R9-17-20210213","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1023\/A:1015926119947","article-title":"Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters.","volume":"6","author":"Ignarro","year":"1989","journal-title":"Pharm Res"},{"key":"R10-17-20210213","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/306174a0","article-title":"Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation.","volume":"10-","author":"Rapoport","year":"1983","journal-title":"Nature"},{"key":"R11-17-20210213","doi-asserted-by":"crossref","first-page":"10040","DOI":"10.1074\/jbc.M411991200","article-title":"Resistance to endotoxic shock in endothelial nitric oxide synthase (eNOS) knockout mice.","volume":"280","author":"Connelly","year":"2005","journal-title":"J Biol Chem"},{"issue":"7","key":"R12-17-20210213","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/00003246-199607000-00026","article-title":"Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat.","volume":"24","author":"Liu","year":"1996","journal-title":"Crit Care Med"},{"key":"R13-17-20210213","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells.","volume":"332","author":"Yanagisawa","year":"1998","journal-title":"Nature"},{"key":"R14-17-20210213","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1476-5381.1995.tb13322.x","article-title":"Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type.","volume":"114","author":"Davenport","year":"1995","journal-title":"Br J Pharmacol"},{"key":"R15-17-20210213","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0006-291X(92)90826-7","article-title":"The endothelin ETB receptor mediates both vasodilatation and vasoconstriction in vivo.","volume":"186","author":"Clozel","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"R16-17-20210213","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/01.CIR.89.3.1203","article-title":"Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.","volume":"89","author":"Seo","year":"1994","journal-title":"Circulation"},{"issue":"3","key":"R17-17-20210213","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1440-1681.1999.03027.x","article-title":"Chronic studies on the interaction between nitric oxide and endothelin in cardiovascular and renal function.","volume":"26","author":"Pollock","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R18-17-20210213","doi-asserted-by":"crossref","first-page":"9797","DOI":"10.1073\/pnas.85.24.9797","article-title":"Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.","volume":"85","author":"De Nucci","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-17-20210213","first-page":"622","article-title":"The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides.","volume":"119","author":"Simonson","year":"1992","journal-title":"J Lab Clin Med"},{"issue":"10","key":"R20-17-20210213","first-page":"953","article-title":"Effects of endothelin and nitric oxide on organ injury, mesenteric ischemia, and survival in experimental models of septic shock.","volume":"24","author":"Iskit","year":"2003","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"R21-17-20210213","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1476-5381.1990.tb14151.x","article-title":"Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.","volume":"101","author":"Rees","year":"1990","journal-title":"Br J Pharmacol"},{"key":"R22-17-20210213","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3565(25)22357-6","article-title":"Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.","volume":"270","author":"Clozel","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"R23-17-20210213","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1152\/physrev.1990.70.4.921","article-title":"Structure and function of small arteries.","volume":"70","author":"Mulvany","year":"1990","journal-title":"Physiol Rev"},{"issue":"1","key":"R25-17-20210213","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1993.1188","article-title":"Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells.","volume":"191","author":"Nunokawa","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"R26-17-20210213","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/01.RES.73.5.808","article-title":"Negative feedback regulation of endothelial cell function by nitric oxide.","volume":"73","author":"Buga","year":"1993","journal-title":"Circ Res"},{"issue":"2-3","key":"R28-17-20210213","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0014-2999(01)00816-0","article-title":"The timing of endothelin and nitric oxide inhibition affects survival in a mice model of septic shock.","volume":"414","author":"Iskit","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"R29-17-20210213","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0092-8674(95)90085-3","article-title":": Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.","volume":"81","author":"MacMicking","year":"1995","journal-title":"Cell"},{"issue":"3","key":"R30-17-20210213","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-2999(91)90910-I","article-title":"Elevation of plasma endothelin concentrations during endotoxin shock in dogs.","volume":"205","author":"Nakamura","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"R31-17-20210213","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1291\/hypres.24.119","article-title":"Role of endothelin-1\/endothelin receptor system in endotoxic shock rats.","volume":"24","author":"Ishimaru","year":"2001","journal-title":"Hypertens Res"},{"issue":"9","key":"R32-17-20210213","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.peptides.2006.03.025","article-title":"Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat.","volume":"27","author":"Yamaguchi","year":"2006","journal-title":"Peptides"},{"issue":"3","key":"R34-17-20210213","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1476-5381.1996.tb15697.x","article-title":"Effect of selective blockade of endothelin ETB receptors on the liver dysfunction and injury caused by endotoxemia in the rat.","volume":"119","author":"Ruetten","year":"1996","journal-title":"Br J Pharmacol"},{"key":"R35-17-20210213","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00024382-199705000-00009","article-title":"Cardiopulmonary dysfunction during porcine endotoxin shock is effectively counteracted by the endothelin receptor antagonist bosentan.","volume":"7","author":"Wanecek","year":"1997","journal-title":"Shock"},{"issue":"8","key":"R36-17-20210213","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/sj.bjp.0704202","article-title":"Effects of the novel selective endothelin ETA receptor antagonist, SB 234551, on the cardiovascular responses to endotoxemia in conscious rats.","volume":"133","author":"Gardiner","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R37-17-20210213","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(99)00774-8","article-title":"Effects on hemodynamics by selective endothelin ETB receptor and combined endothelin ETA and ETB receptor antagonism during endotoxin shock.","volume":"386","author":"Wanecek","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 48","key":"R38-17-20210213","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1042\/CS103S332S","article-title":"Effects of endothelin receptor antagonists on endothelin-1 and inducible nitric oxide synthase genes in a rat endotoxic shock model.","volume":"103","author":"Hirata","year":"2002","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"R39-17-20210213","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/10623320109090800","article-title":"Influence of several methodological procedures utilized to obtain in vitro vascular preparations on endothelial activity.","volume":"8","author":"Rinaldi","year":"2001","journal-title":"Endothelium"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00024382-200803000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T01:28:18Z","timestamp":1738978098000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00024382-200803000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0b013e318142c5df","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}